Min Mi-Hong, Park Jin-Hyong, Choi Mi-Ran, Hur Jong-Hyun, Ahn Byung-Nak, Kim Dae-Duk
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
Central Research Institute, Whanin Pharmaceutical Company, 4F, GBSA, 107 Gwanggyo-ro, Yeongtong-gu, Suwon 16229, Republic of Korea.
Asian J Pharm Sci. 2019 May;14(3):313-320. doi: 10.1016/j.ajps.2018.08.007. Epub 2018 Oct 5.
The aim of this study was to optimize a tablet formulation of dutasteride that is bioequivalent to a commercially available soft gelatin capsule (Avodart). The effect of cyclodextrin on enhancing the aqueous solubility of dutasteride was investigated, after which the formulation was further optimized with solubilizing polymer and surfactant. Among the cyclodextrins tested, the highest solubility was observed when dutasteride was complexed with γ-cyclodextrin. Moreover, the addition of polyvinylpyrrolidone and Gelucire/TPGS further enhanced the solubility of dutasteride. Differential scanning calorimetry (DSC) and powder X-ray diffraction (pXRD) studies demonstrated that dutasteride existed in the amorphous form in the complex. Optimized dutasteride complexes were selected after a pharmacokinetic study in rats, and film-coated tablets were prepared by the direct compression method. dissolution profiles for the tablets of dutasteride complexes were similar to those of the reference. Moreover, pharmacokinetic parameters including the and values after oral administration in beagle dogs were not significantly different from those of the reference with a relative bioavailability of 92.4%. These results suggest the feasibility of developing a tablet formulation of dutasteride using cyclodextrin complex in addition to a solubilizing polymer and surfactant.
本研究的目的是优化度他雄胺的片剂制剂,使其与市售软胶囊(阿夫唑嗪)具有生物等效性。研究了环糊精对提高度他雄胺水溶性的影响,之后用增溶聚合物和表面活性剂对制剂进行了进一步优化。在所测试的环糊精中,度他雄胺与γ-环糊精形成复合物时观察到最高溶解度。此外,添加聚乙烯吡咯烷酮和Gelucire/TPGS进一步提高了度他雄胺的溶解度。差示扫描量热法(DSC)和粉末X射线衍射(pXRD)研究表明,度他雄胺在复合物中以无定形形式存在。在大鼠体内进行药代动力学研究后,选择了优化的度他雄胺复合物,并通过直接压片法制备了薄膜包衣片。度他雄胺复合物片剂的溶出曲线与参比制剂相似。此外,在比格犬口服给药后的药代动力学参数,包括 和 值,与参比制剂无显著差异,相对生物利用度为92.4%。这些结果表明,除了增溶聚合物和表面活性剂外,使用环糊精复合物开发度他雄胺片剂制剂是可行的。